Søren Brunak presented deep learning approaches for analyzing disease trajectories using data from 7-10 million patients in Denmark and the USA. The models predict future outcomes like mortality and specific diagnoses, such as pancreatic cancer, using 15-40 years of patient data. Disease trajectories and explainable AI can generate hypotheses for molecular-level investigations into causal aspects of disease progression. Why it matters: This research demonstrates the potential of large-scale patient data and AI to improve disease prediction and generate hypotheses for further investigation into disease mechanisms relevant to regional healthcare systems.
Researchers at Khalifa University have developed an AI system capable of predicting cardiovascular disease (CVD) risks up to 12 years in advance. The AI model uses data from the Framingham Heart Study to assess long-term CVD risk factors. It outperforms existing methods in predicting CVD incidence over extended periods. Why it matters: This advancement could significantly improve preventative healthcare strategies in the UAE and globally by enabling earlier interventions for individuals at high risk of heart disease.
This paper proposes a machine learning method for early detection and classification of date fruit diseases, which are economically important to countries like Saudi Arabia. The method uses a hybrid feature extraction approach combining L*a*b color features, statistical features, and Discrete Wavelet Transform (DWT) texture features. Experiments using a dataset of 871 images achieved the highest average accuracy using Random Forest (RF), Multilayer Perceptron (MLP), Naïve Bayes (NB), and Fuzzy Decision Trees (FDT) classifiers.
MBZUAI is developing AI algorithms to intelligently process data from wearables and home sensors for remote patient monitoring. The algorithms aim to analyze multiple strands of health data to provide a more comprehensive view of a patient's health, distinguishing between genuine emergencies and benign situations. MBZUAI's provost, Professor Fakhri Karray, believes this approach could handle 20-25% of diagnoses virtually, reducing the burden on healthcare systems. Why it matters: This research could significantly improve healthcare efficiency and accessibility in the UAE and beyond by enabling more effective remote patient monitoring and reducing unnecessary hospital visits.
Professor Eran Segal presented The Human Phenotype Project, a longitudinal cohort study with over 10,000 participants. The project aims to identify molecular markers and develop prediction models for disease using deep profiling techniques including medical history, lifestyle, blood tests, and microbiome analysis. The study provides insights into drivers of obesity, diabetes, and heart disease, identifying novel markers at the microbiome, metabolite, and immune system level. Why it matters: Such large-scale phenotyping initiatives could inform personalized medicine approaches relevant to the Middle East's specific health challenges.
MBZUAI Professor Agathe Guilloux developed the SigLasso model to forecast hospitalizations using real-time data from Google and Météo France during the COVID-19 pandemic. The model integrates mobility data and weather patterns to predict hospitalization rates 10-14 days in advance. SigLasso outperformed industry standards like GRU and Neural CDE in reducing reconstruction error. Why it matters: This research demonstrates the potential of AI to improve healthcare resource allocation and crisis management by accurately predicting patient flow using readily available data.
KAUST and King Faisal Specialist Hospital and Research Centre (KFSHRC) are collaborating to develop an RNA sequencing tool to improve the diagnosis rate of genetic diseases. The tool analyzes RNA data to find aberrant transcripts and mutations, building on KFSHRC's clinical data and KAUST's computational expertise. The team has already solved cases that DNA sequencing alone could not, including a case of a young child with brain damage caused by a recessive gene mutation. Why it matters: This collaboration can improve disease management and preventative services in the region, directly contributing to Saudi Arabia’s national research priority of health and wellness.